Covered recipient · General Payments record
WILLIAM CURRIE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$993.80
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $421.48 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $169.38 | 12 |
| Lilly USA, LLC | $70.92 | 4 |
| Novo Nordisk AS | $59.24 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.64 | 2 |
| Acerta Pharma LLC | $32.40 | 2 |
| Abbott Laboratories | $19.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.78 | 1 |
| Amgen Inc. | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.85 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125105489 | CMS |
| ABBVIE INC. | $19.35 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523204 | CMS |
| ABBVIE INC. | $11.91 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523206 | CMS |
| ABBVIE INC. | $11.52 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523208 | CMS |
| ABBVIE INC. | $5.49 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523210 | CMS |
| ABBVIE INC. | $26.34 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523212 | CMS |
| ABBVIE INC. | $6.47 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523214 | CMS |
| ABBVIE INC. | $12.54 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523216 | CMS |
| ABBVIE INC. | $23.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523218 | CMS |
| ABBVIE INC. | $11.19 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523220 | CMS |
| ABBVIE INC. | $20.86 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523222 | CMS |
| ABBVIE INC. | $15.85 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523224 | CMS |
| ABBVIE INC. | $3.97 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103523226 | CMS |
| Amgen Inc. | $13.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534760 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.99 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105846419 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.41 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104430905 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.78 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086128488 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.26 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118041368 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.38 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118041370 | CMS |
| Lilly USA, LLC | $21.03 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135497342 | CMS |
| Lilly USA, LLC | $16.64 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135470275 | CMS |
| Lilly USA, LLC | $15.43 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135504456 | CMS |
| Lilly USA, LLC | $17.82 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135482195 | CMS |
| Novo Nordisk Inc | $18.11 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097678085 | CMS |
| Novo Nordisk Inc | $20.77 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097287647 | CMS |
| Novo Nordisk Inc | $20.36 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096621430 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.